杭州维纳安可医疗科技有限责任公司是一家以临床需求导向驱动创新医疗技术研发的高科技公司，旨在为临床提供最佳医疗解决方案。
公司的核心技术以完全自主研发的不可逆电穿孔技术为基础。不可逆电穿孔组织消融技术具有非冷非热、选择性消融的显著性优势，可实现病灶完全消融的同时保留邻近重要管道结构完整性，是实现“消除病灶、降低损伤”的最新利器。因此，被誉下一代的组织消融技术。
维纳安可研发团队是肿瘤不可逆电穿孔理论与实践的先驱者和开拓者，自2000年起在国际上率先提出不可逆电穿孔治疗肿瘤的新思路以来，已经先后提出和研发三代不可逆电穿孔技术，一直引领着全球不可逆电穿孔医疗产品的升级换代。
“微纳刀”是团队最新自主研发成果的结晶，是最新一代不可逆电穿孔技术（SIRE）产品，其突破了传统不可逆电穿孔产品对麻醉要求高、范围小、布针难等问题，无需使用肌肉松弛剂、且对患者心率无影响，可在局麻或镇静下实现更安全、高效的组织或肿瘤消融。
公司聚焦肿瘤微创消融领域，旨在有机结合各种最新微创医疗技术，为患者提出最佳治疗手段，以达到帮助病人减轻病痛、提高生活质量和延长生存期（OS）的目的。
Hangzhou Winner-Onco Medical Technology Co., Ltd. is a high-tech company that focuses on innovative research and development of medical technologies driven by clinical demands, aiming to provide the best medical solutions for clinical patients.
Our core technology is based on the completely independent development of the irreversible electroporation (IRE) technique. IRE offers significant advantages of non-thermal, non-cold and selective ablation. It enables complete ablation of lesions while preserving the integrity of adjacent vital duct structures, making it the latest “weapon” in achieving "lesion elimination and damage reduction." Therefore, it is hailed as the next generation of tissue ablation technology.
Winner-Onco teams are the pioneers and trailblazers in the field of irreversible electroporation theory and practice for tumor treatment. Since 2000, they have been at the forefront of proposing a novel approach for tumor treatment using irreversible electroporation internationally. They have successively proposed and developed three generations of irreversible electroporation technology, consistently leading the global advancement and upgrading of irreversible electroporation medical products.
“Wknife” is the culmination of our team's cutting-edge research and development efforts. It represents the latest advancements in irreversible electroporation technology (SIRE). It has overcome the challenges associated with traditional irreversible electroporation products, such as high anesthesia requirements, limited range, and difficulties in needle placement. The " Wknife " eliminates the need for muscle relaxants and has no adverse effects on the patient's heart rate. It can achieve a safer and more efficient tissue or tumor ablation under only local anesthesia or sedation.
Winner-Onco company is dedicated to the fields of minimally invasive tumor ablation, and we will continuously strive for optimizing and seamlessly integrating various cutting-edge minimally invasive medical technologies. Our goal is to provide patients with the best treatment solution, aiming to patients’ alleviate pain, enhance their quality of life, and extend overall survival (OS).
